Gelonghui, May 10 | Huiyu Pharmaceutical (688553.SH) said on an interactive platform that the company has not yet entered the registration stage for research and development projects applying synthetic biology technology, which will not have an impact on the company's performance at this stage and in the next two to three years.
汇宇制药(688553.SH)：尚未有应用合成生物学技术研发的项目进入到注册阶段
Huiyu Pharmaceutical (688553.SH): No research and development projects using synthetic biology technology have entered the registration stage
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.